Introduction
Fetal gene therapy is a novel therapeutic approach for the treatment or amelioration of congenital diseases that can result in lifelong disabilities or mortality. 1 The transfer of genes at defined fetal ages and based on developmental milestones permits the targeting of expanding stem and progenitor cell populations ensuring persistent and stable transgene expression for a lifetime. Several studies have demonstrated efficient gene transfer using lentiviral vectors in a variety of animal models [2] [3] [4] including non-human primates. 5, 6 Lentiviral vectors can efficiently mediate gene transfer in a wide range of dividing and nondividing quiescent cells, 7 and maintain gene expression for extended periods of time. Differences in the transcriptional pattern in transduced tissues that may occur under varied experimental conditions include the type of viral construct used, the viral titer transferred, and the timing of fetal gene delivery, all of which can help to determine the best conditions for future human application.
In this study, we assessed the level of gene transduction and expression by using TaqMan real-time PCR and reverse transcription PCR (RT-PCR), respectively. Rhesus monkey fetuses were administered lentiviral vectors (1 Â 10 7 -2 Â 10 8 infectious particles/fetus) by the intraperitoneal (i.p.) or intrahepatic (i.h.) routes under ultrasound guidance at 50710 days gestation. The lentiviral vectors contained the enhanced green fluorescent protein (EGFP) transgene driven by the MND or CMV promoters. Tissue harvests were performed at term or 3 months postnatal age, and vector biodistribution and the level of gene marking were assessed by real-time PCR. Gene expression was determined by direct tissue fluorescence and by calculation of the relative levels of mRNA EGFP transcripts using real-time RT-PCR. These studies have shown that: (1) gene transfer at 40 days gestation (first trimester) resulted in a more diffuse distribution of the vector compared to administration at 60 days gestation (early second trimester); (2) administration of the lentiviral vector with the MND promoter by the i.p. or i.h. routes resulted in vector biodistribution to multiple tissues and similar levels of gene transfer when compared to the lentiviral vector with the CMV promoter; and (3) transgene expression analysis in transduced tissues showed the presence of mRNA transcripts that correlated with the level of gene transfer.
Results
The study groups are shown in Table 1 . In all, 21 animals were assigned to the study on a rotational basis. Seventeen fetuses were administered the lentiviral-MND vector by the i. Gene transfer was performed at 50710 days of gestation. Fetuses were delivered at term for tissue harvest (3 of 3) or by cesarean section for postnatal studies (18 of 18) . There was no evidence of adverse effects either prenatally or postnatally in any of the animals included in these studies.
Growth and development
Sonographic measurements of the fetal head, abdomen, and limbs, in addition to anatomical evaluations, were assessed weekly postgene transfer as described previously. 8 All parameters evaluated were compared to normative growth charts for rhesus fetuses and found to be within normal limits (data not shown). Infants were raised in the nursery, with daily monitoring of food intake and body weights. Animals were pair housed with another infant of similar age in each of the groups. Complete blood counts (CBCs) and clinical chemistry panels were unremarkable and comparable to agematched controls (data not shown).
Validation experiment
Quantitative real-time RT-PCR has been shown to be an accurate and powerful method for quantitation of gene expression. 9, 10 We utilized the 2 ÀDDC T (C T ¼cycle threshold) method for relative quantitation of the amount of the EGFP reporter in transduced tissues. This method provides a measure of the change in expression of the target gene relative to an untreated control. Examples of analyses of gene expression using the 2 ÀDDC T method are available in the literature. 11 This method utilizes arithmetic formulas as described in the Applied Biosystems User Bulletin (P/N 4303859) (Applied Biosystems). To validate this method, the efficiency of target amplification (EGFP) and reference amplification (elongation factor 1a (EF1a)) must be approximately equal. As shown in Figure 1 , the plot of log copy number versus DC T for the EGFP reporter to the EF1a housekeeping gene reveals that the difference in the absolute value of the slope of the log copy number versus DC T is less than 0.1, and therefore the efficiency of the two assays can be considered equivalent.
Effect of gene transfer at 40 days gestation on lentiviral biodistribution
To study the effect of gestational age at the time of fetal gene delivery, we selected four animals for analysis.
Fetuses were injected i.p. with an average of 2.5 Â 10 7 (range 1-5 Â 10 7 ) lentiviral-MND infectious particles at 40 days gestation (Table 1 ). Vector biodistribution and the level of gene marking were assessed in multiple tissues (cerebrum, lung, trachea, esophagus, thorax, heart, pericardium, thymus, liver, spleen, pancreas, axillary and mesenteric lymph nodes, kidneys, adrenals, gonads, stomach, colon, diaphragm, omentum, peritoneum, bone marrow) 7 months postgene transfer (3 months postnatal age). Real-time PCR analyses demonstrated systemic spread of the vector, which predominated in the abdominal cavity (Figure 2 ). For all animals examined, the percentage of gene transduction was highest in the omentum, diaphragm, and peritoneum, with an average (and range) of 1.7% (0.01-4%), 1.4% (0.02-3%), and 0.6% (0.01-1.3%), respectively. The level of gene transduction was four-fold lower in the gonads (females 1.5% (0.6-2.2%), males 0.034% (0-0.05%)); 20-fold lower in the stomach and colon (0.06% (0.02-0.1%)); and between 100-and 1000-fold lower for the rest of the abdominal organs examined (0.008% (0.0001-0.02%)). For nonabdominal organs, the percentage of gene transduction was highest in the thorax (0.8%); the trachea, esophagus, lung, and pericardium (0.05%); and the cerebrum, heart, thymus, and bone marrow (o0.005%). The quantity of the EGFP transgene in the diaphragm and omentum was significantly higher (Po0.05) when compared to the adrenals, kidneys, liver, cerebrum, lung, trachea, heart, pericardium, thymus, axillary and mesenteric lymph nodes, pancreas, spleen, stomach, and bone marrow.
Evaluation of gene transfer at 60 days gestation and persistence of gene marking in tissues
Fetuses were injected i.p. at 60 days gestation, with an equivalent dose of the lentiviral-MND vector (2.5 Â 10 7 infectious particles/fetus), and tissues were analyzed at 3 months postnatal age (6 months postgene transfer) ( Figure 2 ). Vector distribution and levels of gene marking in organs and tissues of the peritoneal cavity were found to be similar when transfers at 40 and 60 days of gestation were compared. In contrast, the level of gene transfer to nonabdominal organs was higher in the animals injected at 40 days gestation. The average fold difference in the level of gene transduction in the animals in the 40-day group versus the 60-day group was twofold for the heart and pericardium, three-fold for the Figure 1 Plot of log input amount versus DC T . Standard curves for EF1a and EGFP were utilized to calculate the C T at five series of 10-fold template dilution. The DC T between EGFP and EF1a was utilized to determine the variation with the template dilution. The plot of log copy numbers versus DC T shows that the slope is approximately zero. (2) i.p. ¼ intraperitoneal; i.h. ¼ intrahepatic.
Gene transfer efficiency of lentiviral vectors DF Jimenez et al cerebrum and trachea, seven-fold for the esophagus and lung, and 50-fold for the thorax. However, these differences were not statistically significant (P40.05). The level of gene marking (EGFP copy numbers/50 000 genome equivalents (GE)) is shown in Table 2 for fetuses injected i.p. at either 40 or 60 days of gestation. We also assessed the effect of vector persistence 4 and 7 months postgene transfer (gene transfer at 50 gestation days). In all, 15 tissues were examined (cerebrum, thymus, heart, lung, diaphragm, liver, spleen, pancreas, kidneys, adrenals, gonads, stomach, colon, mesenteric lymph nodes, bone marrow) (Figure 3) . No significant differences were found (P40.05) in the level of gene marking in tissues. At both post-transfer time points assessed, the average percentage of gene transduction was higher in the diaphragm (1.5%) and gonads (females 3%, males 0.1%); the pancreas, spleen, lungs, and stomach (0.02-0.2%); the colon, liver, pancreas, mesenteric lymph nodes, cerebrum, heart, and adrenals (0.01-0.02%); and the thymus, kidneys, and bone marrow (o0.01%).
Comparison of the level of fetal gene transfer after i.p. and i.h. administration
We also investigated the effect that the route of delivery had on lentiviral transduction in various organs by i.p. and i.h. administration of the lentiviral-MND vector at a range of 1 Â 10 7 -5 Â 10 7 infectious particles/fetus. Both tissue marking and gene expression were assessed 7 months postgene transfer (Figure 4a) (Table 3) . Biodistribution of the EGFP transgene and the level of gene transduction were similar; no significant differences (P40.05) were found in the level of gene marking when comparing i.p. with i.h. routes of administration. The percentage of gene transduction with i.h. administration was higher within intra-abdominal organs, although we also observed the spread of vector to locations distant 7 lentiviral-MND-EGFP infectious particles at 40 days gestation (first trimester) or 60 days gestation (early second trimester), and tissues were harvested at 3 months postnatal age (7 months postgene transfer). The level of gene marking was examined in multiple tissues, and no significant differences (P40.05) were found. GE ¼ genome equivalents; LN ¼ lymph nodes. Includes cerebrum, lung, trachea, esophagus, thorax, heart, pericardium, thymus, axillary lymph nodes, and bone marrow.
Gene transfer efficiency of lentiviral vectors DF Jimenez et al from the site of injection. The highest level of gene marking was found in the diaphragm, which suggests that in some instances, i.h. injection may result in leak of vector supernatant from the liver to the diaphragm or into the peritoneal cavity. The percentage of gene transduction in tissues of animals injected i.h. was 1-3% in the diaphragm and gonads (similar to i.p. administration, the level of gene transduction in males (0.1%) was lower than in females (6%)). Other findings included 0.1-0.9% in the stomach, colon, pancreas, spleen, trachea, and lung, and o0.05% for the rest of the tissues examined. For comparison, we also assessed differences in the levels of tissue transduction between i.p. and i.h. administration in fetuses injected with 2 Â 10 8 lentiviral-CMV infectious particles under similar experimental conditions. Analyses were performed on all tissues and biodistribution and levels of gene marking were again found to be similar ( Figure 4b ) ( Table 4 ). Both approaches resulted in percentages of tissue transduction in the range of 2-10% in the gonads (males 1%, females 10%); 0.2-1% in the liver, spleen, pancreas, mesenteric lymph nodes, and colon; 0.02-0.2% in the kidneys, adrenal, thymus, heart, lung, and stomach; and p0.005% in the cerebrum and bone marrow. Statistical analysis did not show significant differences in the level of gene marking between the two groups (P40.05).
Comparison of the levels of gene transcription between fetuses injected i.p. at 40 or 60 days gestation
We determined the level of gene transcription as a measure of the quantity of gene expression. Since it is unlikely that distribution of the lentiviral vector will be homogeneous, differences may exist in the level of gene transduction and expression from two different specimens from the same tissue. Therefore, we chose to determine the amount of the EGFP transgene and mRNA transcripts present in the same specimen. For this purpose, genomic DNA and total RNA were isolated from a 100 mm frozen section of abdominal organs that previously tested positive for EGFP (see Figure 2 ). Nucleic acid samples were then utilized for calculation of the EGFP transgene and mRNA transcripts by realtime PCR and RT-PCR, respectively. Analysis showed that the EGFP transgene was found predominantly within organs of the abdominal cavity, and levels of gene transduction were confirmed to be highest in the diaphragm, omentum, and peritoneum. In these tissues, the level of gene marking was in the range of 3-to 2200-fold higher compared to other organs; in addition, the levels of mRNA EGFP transcripts were in the range of 11-to 680-fold higher (Figure 5a and b) ( Table 5) . In nonabdominal organs, the level of gene transduction was on average seven-fold (range [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] higher in the animals injected at 40 versus 60 days gestation. No mRNA EGFP transcripts were found in nonabdominal organs of the animals injected at 60 days gestation (Figure 5b ).
In addition, the quantity of the EGFP transgene in tissues correlated (Po0.05) with the amount of mRNA EGFP transcripts in four of six animals examined. The nonparametric Spearman's rho was used to calculate a weighted average correlation as an estimate of the correlation between DNA and RNA of 0.49. This result indicates a moderate level of correlation between DNA and RNA levels.
Comparison of the levels of gene transduction and transcription in fetuses injected with the lentiviral-MND and lentiviral-CMV vectors and the effect of viral titer
Fetuses were injected i.p. with 2 Â 10 8 infectious particles at 50 days gestation and tissues harvested at 3 months 7 lentiviral infectious particles i.p. at 50710 days gestation and tissues were harvested at term or 3 months postnatal age (4-7 months postgene transfer). The level of gene marking was examined in multiple tissues and no significant differences (P40.05) were found. GE ¼ genome equivalents; LN ¼ lymph nodes.
Gene transfer efficiency of lentiviral vectors DF Jimenez et al postnatal age. Widespread biodistribution of the lentiviral-CMV vector was observed after i.p. injection. Gene transduction occurred preferentially within organs of the abdominal cavity. The percentage of gene transduction was 10-20% in the gonads (males 3.5%, females 45%); 1-9% in the pancreas, spleen, liver, mesenteric lymph nodes, adrenals, and colon; 0.1-0.9% in the stomach, lung, kidneys, and heart, and o0.05% in the thymus, bone marrow, and cerebrum. These results demonstrated that the level of gene transduction with the lentiviral-CMV vector was higher when compared organ-to-organ with the lentiviral-MND vector group. We also tested for differences in the level of gene expression and the presence of direct EGFP fluorescence. Genomic DNA and total RNA were isolated from 100 mm frozen sections from abdominal organs (liver, spleen, pancreas, kidneys, adrenals, mesenteric lymph node, stomach, colon), and the level of EGFP transduction and transcription compared between both lentiviral vector promoters (Table 6a and ) is likely a factor contributing to the differences observed in the level of gene transduction and expression between both groups.
EGFP tissue fluorescence
We determined whether the detection of mRNA in tissues was associated with EGFP fluorescence. Here, 10 mm frozen tissue sections were obtained and expression of EGFP was assessed by direct fluorescence microscopy. Tissue specimens were analyzed from animals that showed the highest levels of mRNA gene transcripts. EGFP fluorescence was only observed in focal areas of the splenic capsule of one of the fetuses that received the lentiviral-CMV vector ( Figure 6 ). No EGFP fluorescence was detected in tissues from animals injected with the lentiviral-MND vector.
Assessment of gene transfer efficiencies in peripheral blood and bone marrow 
Discussion
Many genetic disorders can be diagnosed in humans very early in gestation. 12 Thus, fetal gene therapy can provide a therapeutic option for the treatment of a number of these genetic diseases, which can alter normal development prior to birth. Previous studies in nonhuman primates support the view that direct fetal injection of viral vectors is an effective method for obtaining high levels of persistent gene transduction in a wide array of tissues. 5, 6 In the current study, we have utilized quantitative real-time PCR assays to calculate the level of lentiviral transduction and the EGFP mRNA transcripts in transduced tissues. This approach allows one to make direct comparisons between animals under a variety of experimental conditions such as gene transfer at different gestational ages, different routes of administration, and different vector constructs.
We selected the HIV-1-derived lentiviral vector for gene transfer because lentiviral vectors have the capacity to permanently integrate into the cellular genome, transduce quiescent nondividing cells, and suppress RNA splicing during vector preparation. 13 Numerous studies have utilized lentiviral vectors for efficient transduction and expression of reporter or therapeutic transgenes. 2, 5, 14, 15 Thus, these vectors constitute ideal candidates for gene therapy, once safety is proven. The delivery of 2.5 Â 10 7 HIV-1-derived lentiviral-MND infectious particles by i.p. injection at 50710 days gestation resulted in both local distribution and systemic spread to more distant sites. Gene transduction and expression persisted over time, and the EGFP transgene and mRNA 6 EF1a mRNA transcripts. Absolute values were determined by generating a standard curve using known amounts of plasmid EGFP. First, the C T (cycle threshold) for the EGFP (target amplicon) and the EF1a (endogenous control) were determined. Differences for the C T (DC T ) of the EGFP and EF1a were calculated to normalize for differences in the RNA extractions and in the efficiency of the reverse transcription step. The 2 DC T give a predictive copy number difference between EF1a and EGFP transcript mRNA.
Gene transfer efficiency of lentiviral vectors DF Jimenez et al transcripts were detected in tissues up to 7 months postgene delivery, the latest time point assessed in this study. Gene transduction was detected mainly within abdominal organs, and the highest levels were found within the omentum, diaphragm, and peritoneum. However, no significant differences (Po0.05) were found on pair-wise comparison of gene transfer in abdominal tissues between 40 and 60 days gestation. These findings are similar to those reported by Lipshutz et al, 16, 17 where i.p. delivery of adenovirus in fetal mice was shown to result in efficient transduction of the peritoneum, intestinal serosa, and the outer surface of abdominal organs. In the study described here, high levels of gene transfer were found in the gonads of females, although few germ cells were positive for the transgene when using laser capture microdissection and PCR analysis. These findings are more fully addressed in a separate publication. 18 Other investigations by our group have shown that direct injection of lentiviral vector supernatant into fetal organs such as the heart or lung does not result in gene transfer to germ cells. 19 The EGFP transgene was also detected in nonabdominal organs such as the cerebrum, lung, esophagus, trachea, heart, pericardium, and thymus. Gene transduction in these tissues was higher in fetuses injected at 40 days gestation when compared to 60 days gestation. These differences are likely due to changes related to (1) size at the time of gene transfer (B10 g body weight at 40 days gestation versus B50 g at 60 days gestation), and (2) the stage of development of the diaphragm at the time of gene delivery that may facilitate access of the vector to the thoracic cavity and the diaphragmatic lymphatic drainage system. It has been hypothesized that the systemic vector spread observed could be the result of direct entry of vector supernatant by diffusion into the circulation and/or lymphatic system, or could reflect the migration of transduced progenitor cells into these organs during development. It has also been proposed that viral particles may enter through the stomata located in the subdiaphragmatic peritoneum. 20, 21 Peritoneal stomata were defined by Allen 22 as normal openings of the underlying lymphatics in the peritoneal cavity. These openings are a part of an important drainage system of bulk fluid, cells, and particles out of the peritoneal cavity. 23, 24 Widespread distribution has also been reported after i.p. delivery of viral vectors in a variety of species. 17, [25] [26] [27] [28] In addition, it is possible that random cell and tissue transduction may occur; further work is needed to address these possibilities.
Regarding the level of gene expression, mRNA EGFP transcripts were found in tissues with higher levels of gene transduction. In 60% of the animals, there was a significant correlation (Po0.05) between the levels of the EGFP transgene and transcripts present in the same tissue. Overall, the quantity of the EGFP transgene in tissues correlated with the level of mRNA transcripts. Despite the fact that we found mRNA transcripts in most of the tissues transduced, EGFP fluorescence was only found on the splenic capsule of a fetus injected i.p. with the lentiviral-CMV vector. Other studies have shown that i.p. delivery results primarily in transduction of the serosa of intestinal organs such as the liver capsule, 16 although in these studies the majority of expression was found in the peritoneum and peritoneal serosa. Our other studies with monkeys have shown that the lentiviral-CMV vector results in high levels of EGFP fluorescence in the peritoneum, which can persist for up to 3 years postgene delivery (unpublished observations). We also evaluated whether the level of gene transduction diminished between birth and 3 months postnatal age (7 months postgene transfer). Although we found that the number of vector genome copies decreased with increasing postnatal age, these differences were not statistically significant. Tissue biodistribution and transduction were also characterized after i.h. delivery and revealed a similar biodistribution and levels of gene marking in tissues when compared to the i.p. approach. The amount of the EGFP transgene found in the liver was not higher than that in the peritoneal cavity. This finding contrasts with other studies with adenoviral vectors that have shown that i.h. delivery in fetal mice resulted in transduction of the hepatic parenchyma. 21 While gene transfer was also reported in the diaphragm and other organs distant from the site of injection, this outcome was most likely due to the leak of vector supernatant into the peritoneal cavity, similar to findings in the study described here.
We have also characterized the effect of lentiviral titer used at the time of fetal injection. When rhesus monkey fetuses were injected i.p. with the lentiviral-CMV vector, we found that, on average, the level of gene transduction and expression in the liver, spleen, pancreas, kidneys, mesenteric lymph nodes, stomach, and colon were 150-and 70-fold greater than with the injection of 2.5 Â 10 7 infectious particles of the lentiviral-MND vector. MND is a modification of a retroviral promoter originally designed to drive expression in hematopoietic cells, 7 although short-term gene expression has been shown to occur in the liver and kidney in a fetal dog model. 29 Both lentiviral vectors demonstrated gene expression in vivo that persisted up to 7 months postgene delivery. While CMV is a strong viral promoter, several mechanisms have been proposed for transient expression, such as deletion of transduced cells or promoter downregulation. [30] [31] [32] Even if results of this study suggest that the vector construct containing the CMV promoter was more successful than MND, we cannot conclude that CMV is a more efficient promoter than MND because the quantity of virus injected differed. These results do, however, suggest that the level of transduction is dose-dependent, Figure 6 Whole-tissue fluorescence. The EGFP transgene was observed in focal areas on the splenic capsule (a) from OCT-embedded tissue sections ( Â 40, transverse section; brightfield (b)).
Gene transfer efficiency of lentiviral vectors DF Jimenez et al which is in agreement with other published studies. 16, 17, 33, 34 In this study, transduction of PBMCs or immunoselected CD34 + cells in blood and bone marrow was very low, and unlikely to be of clinical significance. These findings are supportive of studies that have shown that HIV-1-derived lentiviral vectors do not transduce rhesus hematopoietic stem and progenitor cells to the same degree as human cells 35 due to a restriction mechanism that has recently been described. 36 Finally, we also analyzed durability in relation to the time of fetal gene delivery and demonstrated that i.p. injection of the lentiviral vector resulted in prolonged expression of the EGFP transgene in abdominal organs, that gene expression persisted for up to 7 months postadministration, and that all animals were of a normal size with no adverse findings detected and remained healthy during the study period. Together, these observations indicate the potential of fetal gene transfer to be developed into a durable therapeutic modality for the treatment of certain genetic diseases where only a small amount of protein is needed to correct congenital disorders, such as hemophilia.
Materials and methods

Animals
All animal procedures conformed to the requirements of the Animal Welfare Act and protocols were approved prior to implementation by the Institutional Animal Care and Use Committee (IACUC) at the University of California at Davis. Normally cycling, adult female rhesus monkeys (Macaca mulatta) (N ¼ 21) with a history of prior pregnancy were bred and identified as pregnant, using established methods. 37 Pregnancy in the rhesus monkey is divided into trimesters by 55-day increments, with 0-55 days gestation representing the first trimester, 56-110 days gestation representing the second trimester, and 111-165 days gestation the third trimester (term 165710 days). 8 Activities related to animal care (diet, housing) and screening animals for endogenous retroviruses (SRV, STLV) prior to assignment to the study were performed as per standard California National Primate Research Center (CNPRC) operating procedures.
Lentiviral vector preparations
The HIV-1-derived lentiviral vector containing the EGFP and MND or human CMV immediate-early promoters were constructed as described previously. [38] [39] [40] [41] The CCLlentiviral vector was used to generate VSV-G-pseudotyped recombinant lentiviral particles by transient transfection into 293T cells using standard protocols. 39 The lentiviral-MND vector 41 contains: (1) the MND LTR derived from the Myeloproliferative Sarcoma Virus (MPSV) by removal of the 'negative control region', (2) the primer binding site derived from dl587rev virus, and (3) the packaging sequence from the LN vector. 42 
Lentiviral vector administration
All fetuses were sonographically assessed to confirm normal growth and development prior to gene transfer. 8 The dams were administered with ketamine hydrochloride (10 mg/kg) intramuscularly (i.m.) for ultrasound examinations. On the day of gene transfer, the dams were administered with telazol (5-8 mg/kg i.m.), and were aseptically prepared for transabdominal ultrasoundguided fetal gene transfer. A total volume of approximately 150-300 ml of the lentiviral vector supernatant was injected into the peritoneal cavity or within the liver. 5 Fifteen fetuses were injected i.p. and six fetuses were injected i.h. (Table 1) . Postgene transfer, sonographic measurements of the fetal head (biparietal and occipitofrontal diameters, area and circumference), abdomen (area and circumference), and limbs (humerus and femur lengths), in addition to gross anatomical evaluations (axial and appendicular skeleton, viscera, membranes, placenta, and amniotic fluid), were assessed weekly, as described previously, and all measures were compared to normative growth curves for rhesus fetuses. 8 
Pregnancy termination
Fetuses were surgically delivered by hysterotomy (150 days gestation) (N ¼ 3) or newborns were delivered by cesarean section at term (16072 days gestation) (N ¼ 18), and then raised in the nursery for postnatal studies. Umbilical cord blood samples (12 ml) were collected at birth for CBCs, clinical chemistry panels, and for the collection of plasma, serum, PBMCs, and immunoselected cells (see below). Newborns were nursery-reared for the duration of the study. Infant health, food intake, and body weights were recorded daily until tissue harvest. Blood and bone marrow samples were collected monthly (CBCs, clinical chemistry panels, PBMCs, immunoselected cells). Bone marrow (1-2 ml) was collected under ketamine (10 mg/kg i.m.) and local lidocaine using established techniques. 5 
Tissue harvest
Complete tissue harvests were performed at term or 3 months postnatal age using established techniques. 5, 6 Total body weights and measures (hand, foot, humerus, and femur lengths; biparietal and occipitofrontal diameters; head, arm, and chest circumferences; crownrump lengths) were assessed, then all organs were removed and weighed after carefully examining the thoracic and abdominal cavities, and included the cerebrum, lung, thorax (intercostal muscles), trachea, esophagus, heart, pericardium, thymus, spleen, liver, axillary and mesenteric lymph nodes, pancreas, adrenals, kidneys, gonads, gastrointestinal tract, diaphragm, omentum, peritoneum, and bone marrow. All tissues collected for PCR were placed in 1.5 ml microcentrifuge tubes and immediately frozen in liquid nitrogen and stored at pÀ801C. In addition, tissue specimens were either placed in OCT and then quick frozen over liquid nitrogen, or fixed in 10% buffered formalin and embedded in paraffin. Representative 5-6 mm sections were obtained from all tissues and stained with hematoxylin and eosin for routine histopathology.
Hematology, clinical chemistry, and immunoselected cells
Routine CBCs and clinical chemistry panels were performed as described previously. 5, 6 PBMCs were obtained from blood samples collected into EDTA. Briefly, 1-3 ml of blood were obtained from a peripheral vessel (volume dependent on age) or from the umbilical cord at birth, and placed into vacutainer tubes with PBMCs were resuspended in selection buffer (0.5% BSA and 2 mM EDTA in PBS) and incubated for 10 min at 41C with anti-CD32 (nonspecific blocking immunoglobulin to FcRIIA), followed by a 20 min incubation at 41C with anti-CD34 monoclonal antibody (clone 563; StemCell Technologies, Vancouver, BC, Canada). Cells were then incubated with magnetic colloids for 30 min at 41C. Cells were washed with 5 ml selection buffer and centrifuged at 400 g for 5 min, then resuspended in 500 ml of selection buffer, and applied to the separation columns. Separation columns were washed three times, and retained cells were eluted with 1 ml of selection buffer. A second round of separation was performed on the eluted cells. The purity of selected CD34 + cells as assessed by flow cytometry was 97.0171.32% (data not shown). For T-and B-cell selection, CD2, CD4, CD8, and CD19 microbeads were utilized as instructed by the manufacturer (Miltenyi Biotec).
DNA isolation and PCR analysis
Genomic DNA was isolated from tissues using the Gentra System DNA isolation kit, as recommended by the manufacturer (Gentra, Minneapolis, MN, USA). Realtime PCR assays were performed on the ABI PRISM 7700 s Sequence Detection System as reported previously. 43, 44 To determine the percentage of transduced cells in tissues, the calculated number of EGFP copies was normalized to e-globin as an internal control in order to reduce the variability introduced by processing and PCR. The low level of sensitivity of the assay is five copies of the EGFP transgene. The primers and probe sequences for EGFP and e-globin have previously been reported. 44, 45 Total RNA and genomic DNA extraction Gene expression analysis was assessed in EGFP-transduced tissues. Since gene transfer does not result in homogeneous distribution of the EGFP transgene in tissues, we determined both EGFP DNA and RNA from the same sample. Frozen blocks were sectioned at 100 mm using a cryostat (CM3050S, Leica, Bannockburn, IL, USA), and sections were placed into microcentrifuge tubes and stored at pÀ801C until analysis. Genomic DNA and total RNA were simultaneously isolated from frozen sections using the commercial Qiagen DNA/RNA kit (Qiagen, Valencia, CA, USA). To remove contaminating genomic DNA, the total RNA was treated following the DNA-freet DNase treatment (Ambion, Austin, TX, USA).
Reverse transcription of total RNA
Reverse transcription was performed in a 20 ml final volume containing 50 U PowerScript reverse transcriptase (BD Biosciences Clontech, Palo Alto, CA, USA) and following the manufacturer's instructions (Protocol-at-aGlance, PT3396-2; BD Biosciences). The final volume was adjusted to 100 ml with RNase-free water. The cDNA was immediately analyzed or stored at pÀ201C until use.
Real-time TaqMan PCR for quantitation of EGFP cDNA
Real-time TaqMan PCR systems for rhesus monkeys included the housekeeping gene EF1a, the rhesus monkey e-globin gene, and the transgene EGFP, all of which were run in separate plates. The PCR reactions contained 400 nM of each primer and 100 nM of the probe. Reactions were set using the available 2 Â TaqMan PCR Mastermix (Applied Biosystems, Foster City, CA, USA) and 5 ml of cDNA in a final volume of 25 ml. The reactions were placed in 96-well plates and the run amplified in the ABI Prism 7700
s Sequence Detection System (Applied Biosystems). Amplification conditions were 2 min at 501C, 10 min at 951C, and 40 cycles of 15 s at 951C, and 60 s at 601C. Final quantitation was performed using the comparative C T method as described in the User's Bulletin #2 (Applied Biosystems). The results were reported as relative transcription or the n-fold difference relative to a calibrator cDNA (rhesus monkey EF1a). Positive controls and negative controls (water) were included in each run. RT minus reaction was also performed to assure that DNA was removed from the sample.
EGFP whole-tissue fluorescence
Tissue specimens were quick frozen over liquid nitrogen in OCT and stored at pÀ801C, then were sectioned at 10 mm, placed on glass microscope slides (Superfrost, Fisher Scientific, Pittsburgh, PA, USA), and stored at pÀ201C until analysis. Slides were examined using an Olympus Bx61 microscope for detection of EGFP fluorescence. Images were captured with a Microscope Control Software Olympus Microsuitet-B3SV v3.2 imaging system (SoftImaging Systems, GmbH, Lakewood, CO, USA).
Data analysis
Statistical analysis was performed using statistical software (Statview 512+, version 4.5, Brainpower Inc., Calabasas, CA, USA) and the Mann-Whitney rank-sum test. 46 Statistical significance was assigned to all values where Po0.05. The correlation between the percent EGFP transduction and percent of mRNA transcripts in multiple tissues was assessed using the nonparametric Spearman's correlation test.
